Protocol for derivation of organoids and patient-derived orthotopic xenografts from glioma patient tumors.

Publikation: Beitrag in FachzeitschriftForschungsartikelBeigetragenBegutachtung


  • Anais Oudin - (Autor:in)
  • Virginie Baus - (Autor:in)
  • Vanessa Barthelemy - (Autor:in)
  • Carina Fabian - , Luxembourg Institute of Health (Autor:in)
  • Eliane Klein - (Autor:in)
  • Monika Dieterle - (Autor:in)
  • May Wantz - (Autor:in)
  • Ann-Christin Hau - (Autor:in)
  • Claire Dording - (Autor:in)
  • Amandine Bernard - (Autor:in)
  • Alessandro Michelucci - (Autor:in)
  • Yahaya A Yabo - (Autor:in)
  • Georgia Kanli - (Autor:in)
  • Olivier Keunen - (Autor:in)
  • Rolf Bjerkvig - (Autor:in)
  • Simone P. Niclou - (Autor:in)
  • Anna Golebiewska - (Autor:in)


Tumor organoids and patient-derived orthotopic xenografts (PDOXs) are some of the most valuable pre-clinical tools in cancer research. In this protocol, we describe efficient derivation of organoids and PDOX models from glioma patient tumors. We provide detailed steps for organoid culture, intracranial implantation, and detection of tumors in the brain. We further present technical adjustments for standardized functional assays and drug testing. For complete details on the use and execution of this protocol, please refer to Golebiewska et al. (2020).


FachzeitschriftSTAR Protocols
PublikationsstatusVeröffentlicht - 12 Mai 2021
Extern publiziertJa

Externe IDs

PubMed 34027491
PubMed PMC8132120
Scopus 85105598446